New Tests

Catch Up with New and Enhanced Tests in All Methodologies

Innovation is one of NeoGenomics’ company values. We mean that literally – innovation is one of our Core Values – and we take it personally. We are continually refining and adding new assays in hereditary and somatic molecular genetics, IHC, FISH, flow cytometry, and cytogenetics to keep our test menu at the forefront of cancer diagnostics. To stay up-to-date with our latest news, please sign up for our newsletter here.


Please Review Our List of Recently Launched Tests:

 

An Introduction to NeoGenomics' Diagnostic Services